NEW YORK, Dec. 14, 2023 /PRNewswire/ — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of ChargePoint Holdings, Inc. (NYSE: CHPT) between June 1, 2023 and November 16, 2023, both dates inclusive (the “Class Period”), of the important January 29, 2024 lead plaintiff deadline. SO WHAT: If you purchased ChargePoint securities… Continue reading ROSEN, TRUSTED INVESTOR COUNSEL, Encourages ChargePoint Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – CHPT
Category: Newswire
Ustekinumab (Stelara) by Janssen Biotech Biosimilars Pipeline Review 2023: Information on Approved Drugs and Drug Candidates in Research and Development as Biosimilar Antibodies
DUBLIN , Dec. 14, 2023 /PRNewswire/ — The “Ustekinumab (Stelara) Biosimilars Pipeline Review” report has been added to ResearchAndMarkets.com’s offering. This product provides basic information on approved drugs and drug candidates in research and development as biosimilar antibodies of Stelara (ustekinumab). Developed by Janssen Biotech, the blockbuster therapeutic antibody STELARA (INN: ustekinumab) is an approved human interleukin-12 and interleukin-23… Continue reading Ustekinumab (Stelara) by Janssen Biotech Biosimilars Pipeline Review 2023: Information on Approved Drugs and Drug Candidates in Research and Development as Biosimilar Antibodies
DAISO NEW STORE OPENING IN STOCKTON, CALIFORNIA
STOCKTON, Calif., Dec. 14, 2023 /PRNewswire/ — Daiso, the renowned global retail chain offering a wide range of affordable and unique products, is thrilled to announce the grand opening at Sherwood Place in Stockton, California on December 30th. “We are thrilled to open our store at Sherwood Place,” said Jack Williams, Chief Retail Operations Officer for… Continue reading DAISO NEW STORE OPENING IN STOCKTON, CALIFORNIA
ROSEN, A TOP RANKED LAW FIRM, Encourages The Estée Lauder Companies Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – EL
NEW YORK, Dec. 14, 2023 /PRNewswire/ — WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of The Estée Lauder Companies Inc. (NYSE: EL) between August 18, 2022 and May 2, 2023, both dates inclusive (the “Class Period”). A… Continue reading ROSEN, A TOP RANKED LAW FIRM, Encourages The Estée Lauder Companies Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – EL
TOP RANKED ROSEN LAW FIRM Encourages Roblox Corporation Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – RBLX
NEW YORK, Dec. 14, 2023 /PRNewswire/ — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of Class A common stock of Roblox Corporation (NYSE: RBLX) between March 10, 2021 and February 15, 2022, both dates inclusive (the “Class Period”), of the important January 26, 2024 lead plaintiff deadline. SO WHAT: If you… Continue reading TOP RANKED ROSEN LAW FIRM Encourages Roblox Corporation Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – RBLX
Thymic Stromal Lymphopoietin (TSLP) Pipeline Review 2023: Approved Drugs and Drug Candidates in Research and Development
DUBLIN, Dec. 14, 2023 /PRNewswire/ — The “TSLP Pipeline Review” report has been added to ResearchAndMarkets.com’s offering. This product provides basic information on approved drugs and drug candidates in research and development targeting thymic stromal lymphopoietin (TSLP) or its receptor (TSLP-R). Thymic Stromal Lymphopoietin (TSLP) is a cytokine that is a key driver of the inflammatory response… Continue reading Thymic Stromal Lymphopoietin (TSLP) Pipeline Review 2023: Approved Drugs and Drug Candidates in Research and Development
Global Biopharmaceutical Fermentation Market Analysis Report 2023-2028: Expanding Biosimilars Market, Continuous Fermentation Processes, and Growing Pipeline of Biopharmaceuticals Bolster Growth
DUBLIN, Dec. 14, 2023 /PRNewswire/ — The “Biopharmaceutical Fermentation Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F” report has been added to ResearchAndMarkets.com’s offering. Global Biopharmaceutical Fermentation Market has valued at USD 24.82 billion in 2022 and is anticipated to project impressive growth in the forecast period with a CAGR of 8.15% through 2028… Continue reading Global Biopharmaceutical Fermentation Market Analysis Report 2023-2028: Expanding Biosimilars Market, Continuous Fermentation Processes, and Growing Pipeline of Biopharmaceuticals Bolster Growth
DMTK DEADLINE TOMORROW: ROSEN, A LEADING LAW FIRM, Encourages DermTech, Inc. Investors to Secure Counsel Before Important December 15 Deadline in Securities Class Action – DMTK
NEW YORK, Dec. 14, 2023 /PRNewswire/ — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of DermTech, Inc. (NASDAQ: DMTK) between May 3, 2022 and November 3, 2022, both dates inclusive (the “Class Period”), of the important December 15, 2023 lead plaintiff deadline. SO WHAT: If you purchased DermTech securities during… Continue reading DMTK DEADLINE TOMORROW: ROSEN, A LEADING LAW FIRM, Encourages DermTech, Inc. Investors to Secure Counsel Before Important December 15 Deadline in Securities Class Action – DMTK
Global Wilms Tumor Treatment Market Research Report 2023: Rise in Chemotherapy Regimens, Rising Incidence of Wilms Tumor, and Advancements in Surgical Techniques Bolsters Growth – Forecast to 2028
DUBLIN, Dec. 14, 2023 /PRNewswire/ — The “Wilms Tumor Treatment Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028” report has been added to ResearchAndMarkets.com’s offering. Global Wilms Tumor Treatment Market has valued at USD 1.24 billion in 2022 and is anticipated to project robust growth in the forecast period with a CAGR… Continue reading Global Wilms Tumor Treatment Market Research Report 2023: Rise in Chemotherapy Regimens, Rising Incidence of Wilms Tumor, and Advancements in Surgical Techniques Bolsters Growth – Forecast to 2028
Similis revolutioniert die Content-Erstellung mit KI-gestütztem AnyoneSwap
Die neue webbasierte SaaS-Lösung AnyoneSwap tauscht das Gesicht eines Models in Fotos oder Videos mithilfe von KI aus und erzielt dabei eine extrem realistische Produktionsqualität „Faceswapping” mit einem Klick verringert den Zeit- und Kostenaufwand für Bearbeitung oder Neuaufnahme erheblich Automatisches De-Aging für professionellen Touch AnyoneSwap hat das Potenzial, Werbung, Filmproduktionen und die Content-Erstellung für soziale… Continue reading Similis revolutioniert die Content-Erstellung mit KI-gestütztem AnyoneSwap